Jazz Pharmaceuticals plc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.3 | $4.1 | $3.8 | $3.7 | $3.1 |
| Operating income | -$0.4 | $0.7 | $0.6 | -$0.1 | $0.2 |
| Net income | -$0.4 | $0.6 | $0.4 | -$0.2 | -$0.3 |
| Balance Sheet | |||||
| Total debt | $5.4 | $6.2 | $5.8 | $5.8 | $6.4 |
| Cash Flow Statement | |||||
| Free cash flow | $1.3 | $1.4 | $1.1 | $1.2 | $0.8 |
| Share repurchases | $0.1 | $0.3 | $0.3 | $<0.1 | $0.0 |
Shares outstanding 62.7M · Free float 65.0%
Annual filing data through FY ended December 31, 2025; float as of August 23, 2026.